Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

DYNACOTINE

Financiado

Signal transduction and allosteric modulation of nicotinic acetylcholine recepto...

Signal transduction and allosteric modulation of nicotinic acetylcholine receptors from ion channel electrophysiology to atomic 3D structures Nicotinic acetylcholine receptors (nAChRs) mediate neuronal synaptic transmission and modulation. They contribute to higher brain functions such as cognition and reward and are important drug targets. Recent studies have revealed... ver más

31/12/2024

CNRS

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-07-18

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2017-ADG: ERC Advanced Grant

I+D

Cerrada hace 7 años

0% 100%

2 Participantes

CNRS

2.28M€ | Lider

ARIES COMPLEX AERONAUTICA

Proyectos interesantes

SAF2013-50085-EXP DINAMICA OPTOELECTRICA DE CANALES IONICOS Y NANODOMINIOS SUB... 87K€ Cerrado

SAF2011-22802 BIOGENESIS, FARMACOLOGIA Y FUNCION DE LOS RECEPTORES NICOTIN... 61K€ Cerrado

BFU2012-38348 RECEPTORES ACOPLADOS A PROTEINAS G Y SUS CANALES IONICOS EFE... 164K€ Cerrado

PCIN-2015-163-C02-01 MODULADORES FOTOCONMUTABLES SINTETICOS PARA MANIPULAR REMOTA... 81K€ Cerrado

SAF2011-30216-C02-01 ALTERACIONES EN LOS PROCESOS DE ACTIVACION Y TRANSDUCCION DE... 30K€ Cerrado

BFU2012-39883 INTERCONEXION ENTRE CALMODULINA, PKC, PIP2, MODULACION Y ENS... 187K€ Cerrado

Últimas noticias

25-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 52 concesiones

25-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 1 concesiones

25-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 6 concesiones

Duración del proyecto: 77 meses Fecha Inicio: 2018-07-18
Fecha Fin: 2024-12-31

Presupuesto del proyecto 2M€

Descripción del proyecto Nicotinic acetylcholine receptors (nAChRs) mediate neuronal synaptic transmission and modulation. They contribute to higher brain functions such as cognition and reward and are important drug targets. Recent studies have revealed that these acetylcholine-gated ion channels display an unanticipated conformational plasticity, adopting multiple allosteric states that shape the time course of their electrophysiological response. To date, a single nAChR structure has been solved at high resolution, and our understanding of the conformational transitions remains so far elusive. To address this challenge, we propose to develop a top-down approach starting from the study of the conformational transitions of nAChRs functionally expressed in cells, and then dissecting the molecular mechanisms on purified proteins. In WP1, we will develop an innovative fluorescence quenching approach to follow the protein motions concomitant with channel opening at the cell membrane. In WP2, we will further exploit this technique on purified proteins, to study the role/requirement of lipids, and their pharmacological crosstalk with allosteric modulators acting at the transmembrane domain. In WP3, the gained knowledge will open original routes to solve 3D structures of nAChRs, in novel conformations and in complex with allosteric modulators. The research will be centered on the major brain nAChRs, primarily the homomeric α7 and also the heteromeric α4β2 nAChRs that are major physiological players and key potential therapeutic targets. This multidisciplinary project combines electrophysiology, fluorescence, pharmacology, membrane protein biochemistry and structural biology, together with in silico modeling, molecular dynamics and ligand docking. The results will provide fundamental insights into the allosteric mechanisms underlying both nAChR function and its modulation by allosteric modulators that hold promises in therapeutics.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores